Sorry, you need to enable JavaScript to visit this website.
Title
Grant Type
Focus Area
Country
Application Due Date
Immunotherapy in Urothelial Carcinoma (USA, Europe, Asia, Latin America, Canada, and Global)
Release Date:
Partner: Merck KGaA, Darmstadt, Germany, EMD Serono
Review Process: Pfizer Internal
Education Oncology All
Promoting timely diagnosis of ATTR-CM in China Competitive Grant Program - internal Pfizer review process
Release Date:
Review Process: Pfizer Internal
Quality Improvement Rare Disease China
Quality Improvement Initiatives to Address Healthcare Barriers for Cardiac Amyloidosis
Release Date:
Partner: National Medical Association
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
2023 Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for Proposals
Release Date:
Partner: Bladder Cancer Canada; EMD Serono
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Junior Investigator Global ATTR Amyloidosis Research ASPIRE (All countries except for the United States)
Release Date:
Review Process: Expert Review Panel
Research Rare Disease All
Improving the Care of Patients Living with Metastatic Breast Cancer (mBC)
Release Date:
Partner: Rethink Breast Cancer
Review Process: Expert Review Panel
Translation: French (link)
Quality Improvement Oncology Canada
Improving the quality of care of patients with urothelial cancer
Release Date:
Partner: Merck Serono
Review Process: Expert Review Panel
Quality Improvement Oncology Italy
Mental Health in Rheumatology
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada
Optimizing Androgen Deprivation Therapy (ADT) in Advanced Prostate Cancer
Release Date:
Partner: Myovant Sciences
Review Process: Pfizer Internal
Education Oncology USA
Optimizing Biomarker-Directed Therapy in Metastatic Colorectal Cancer
Release Date:
Partner: The National Comprehensive Cancer Network®, Fight Colorectal Cancer
Review Process: Expert Review Panel
Quality Improvement Oncology USA
Addressing the Needs of Patients with Mental Health Issues and Dermatological Inflammatory Conditions
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada
Title
Grant Type
Focus Area
Country
Application Due Date
Pneumococcal Disease Prevention
Release Date:
Chronic Pain
Release Date:
Bacterial Infections
Release Date:
Pharmacy Pneumococcal Disease Prevention
Release Date:
Smoking Cessation
Release Date:
Non-Small Cell Lung Cancer
Release Date:
Cardiovascular Risk in Rheumatoid Arthritis
Release Date:
Opioid Pain
Release Date:
Adult Pneumococcal Disease Prevention
Release Date:
Prevention of Stroke in Women
Release Date:
Oncology Educational Needs Assessments
Release Date:
Extension Grant
Release Date: